Sponsored: The Blüm Study - Autism Phase 3 Clinical Trial
Herndon — Do you know a 3-8 year old who has Autism? Would you like to learn about something new in Autism Research?
The Blüm Study is a Phase 3 clinical research study for autism – it is enrolling across the United States! CM-AT, an investigational drug, represents a new approach to treating autism that focuses on the important relationship between the gut and the brain. There are no needles and no pills!
Meet the Blüm Study team from NeuroScience, Inc. Call us at (703) 787-9090 to learn more.